FOXO/TXNIP pathway is involved in the suppression of hepatocellular carcinoma growth by glutamate antagonist MK-801Fuminori Yamaguchi(Kagawa University), Masaaki Tokuda(Kagawa University)BMC CancerOctober 10, 201310.1186/1471-2407-13-468Cited by 96SaveCiteExport RISWatch citationsRelated PapersBoth Ser361 phosphorylation and the C‐arrestin domain of thioredoxin interacting protein are important for cell cycle blockade at the G1/S checkpoint|FEBS Open Bio|2018|15